Calidi Biotherapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q3 2021 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Calidi Biotherapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q3 2021 to Q2 2023.
  • Calidi Biotherapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending June 30, 2023 was 1M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 1M 0 0% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 1M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1M 0 0% Dec 31, 2022 10-Q 2023-08-21
Q3 2022 1M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 1M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 1M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 1M Dec 31, 2021 10-K 2023-03-31
Q3 2021 1M Sep 30, 2021 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.